Therapy Areas: Cardiovascular
26 September 2022 - Artivion, Inc. (NYSE: AORT), a US-based cardiac and vascular surgery company focused on aortic disease, announced on Friday that it has halted the PROACT Xa clinical trial, a prosp...
22 September 2022 - - NTT Research, Inc., a division of Japan-based NTT (TYO: 9432), Medical and Health Informatics Lab has delivered a paper proposing a system design for optimizing dr...
20 September 2022 - Biotechnology companies Rocket Pharmaceuticals Inc (NASDAQ: RCKT) and Renovacor Inc (NYSE: RCOR) on Tuesday announced a definitive agreement under which Rocket will acquire Renovac...
20 September 2022 - - The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending approval of Brukinsa (zanubrutinib) for the treatme...
16 September 2022 - - US-based medical technology company Abiomed (NASDAQ: ABMD) has received two approvals from the US Food and Drug Administration related to clinical research of Impella heart ...
13 September 2022 - - US-based biotechnology company Cellics Therapeutics, Inc has appointed Paul Daruwala as the company's president and chief executive officer, the company said.

W...
Related Headlines